STAT3 and cancer: The treatment of cancer stem cell-like transformed MCF10A cells with metformin (100 μM) significantly inhibited the nuclear translocation of NF-κB and phosphorylation of STAT3 in the cancer stem cells, reduced the MSFE of these cells in vitro, and inhibited the tumorigenic capacity of these cells in vivo [245,261].